医薬品溶出試験サービス市場規模、シェア、動向分析レポート：方法別、剤形別、溶出器具別、地域別、セグメント別予測、2025年～2033年

医薬品溶出試験サービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の医薬品溶出試験サービス市場規模は2033年までに9億6,630万米ドルに達し、2025～2033年のCAGRは8.98%で拡大すると推定されています。

この市場は主に、医薬品開発プロセスの上昇、技術の進歩の増加、高品質な製品の必要性に対する意識の高まり、溶出検査を必要とする様々な慢性疾患のための多数の医薬品の生産の結果として拡大すると予想されています。COVID-19の流行は世界の産業に大きな影響を与えています。製薬会社、バイオテクノロジー企業、その他のエンドユーザーの需要は、コロナウイルス予防薬の開発によって、主に危機の間に提供されました。

2019年末以降、これらの組織は軽度の症状しかないCOVID-19患者の治療として使用できる医薬品の開発に向けて積極的に取り組んでいます。、これらの医薬品開発では、安全性、安定性、有効性にアクセスするために各段階で溶出検査が必要となり、産業の成長に寄与しています。錠剤、カプセル剤、軟膏剤、クリーム剤などの固形剤の物理的評価には、溶出検査が必要です。最も単純なタイプの検査では、薬の錠剤の溶解度や溶解速度を測定します。溶出検査は、様々な状況下での薬剤の放出速度を評価し、吸収、分布、代謝、排泄（ADME）とバイオアベイラビリティ研究におけるin vivo性能の有効性に関する詳細を提供するために実施することができます。

溶出検査は、特定の薬剤が身体の各部位に吸収される速さや遅さ、また投与後にどの程度溶出するかに関する情報を記載しています。これによって企業は、薬剤が患者の体内に入った後に効果的に機能するかどうか、また吸収速度が遅いために生じる悪影響がないかどうかを評価することができます。医薬品の溶出検査には、アッセイを実施し、規制当局への申請を準備するための専門スタッフが必要です。このような要因により、医薬品の溶出検査を担当する専門チームに対する需要が大幅に高まっており、これは産業に好影響を与えると予測されます。

医薬品溶出試験サービス市場レポートハイライト

• 体外セグメントは2024年に最大の収益シェアを占めました。
• 錠剤剤形セグメントが最大のシェアを占め、予測期間中に最も速いCAGRで成長すると予測されます。
• 錠剤は物理的・化学的安定性が高く、体内に送達される薬剤の量を制御できます。
• 溶出器具別では、パドルセグメントは様々な経口剤形をカバーできるため、2024年に産業を支配しました。
• 北米は、公的企業による研究投資の増加と最先端の研究インフラにより、2024年の産業を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品溶出試験サービス市場：変数、動向、範囲

• 市場系統の展望
• 医薬品溶出試験サービス市場力学
• 技術
• 価格モデル分析
• 医薬品溶出試験サービス市場：分析ツール

第4章 医薬品溶出試験サービス市場：方法別、推定・動向分析

• セグメントダッシュボード
• 世界の医薬品溶出試験サービス市場の変動分析
• 世界の医薬品溶出試験サービス市場規模と動向分析（方法別、2021～2033年）
• 体外
• 体内

第5章 医薬品溶出試験サービス市場：剤形別、推定・動向分析

• セグメントダッシュボード
• 世界の医薬品溶出試験サービス市場の変動分析
• 世界の医薬品溶出試験サービス市場規模と動向分析（剤形別、2021～2033年）
• カプセル
• 錠剤
• その他

第6章 医薬品溶出試験サービス市場：溶出器具別、推定・動向分析

• セグメントダッシュボード
• 世界の医薬品溶出試験サービス市場の変動分析
• 世界の医薬品溶出試験サービス市場規模と動向分析（溶出器具別、2021～2033年）
• バスケット
• パドル
• その他

第7章 医薬品溶出試験サービス市場：タイプ、製品、検査、サンプル、最終用途による地域別、推定・動向分析

• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模、予測、動向分析、2021～2033年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業分類
• 医薬品溶出試験サービス市場シェア分析（2024年）
• 企業プロファイル
  • Intertek Group Plc.
  • Avivia BV
  • Almac Group
  • Agilent Technologies, Inc.
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Cambrex
  • Charles River Laboratories
  • Boston Analytical
  • Pace Analytical Life Sciences
  • SOTAX
  • AMRI
  • SGS SA

List of Tables

• Table 1 List of abbreviations
• Table 2 North America pharmaceutical dissolution testing services market estimates and forecasts, by region, 2021 - 2033 (USD Million)
• Table 3 North America pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 4 North America pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 5 North America pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 6 U.S. pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 7 U.S. pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 8 U.S. pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 9 Canada pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 10 Canada pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 11 Canada pharmaceutical dissolution testing services market estimates and forecasts, by
• Table 12 Mexico pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 13 Mexico pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 14 Mexico pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 15 Europe pharmaceutical dissolution testing services market estimates and forecasts, by region, 2021 - 2033 (USD Million)
• Table 16 Europe pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 17 Europe pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 18 Europe pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 19 UK pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 20 UK pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 21 UK pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 22 Germany pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 23 Germany pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 24 Germany pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 25 France pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 26 France pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 27 France pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 28 Italy pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 29 Italy pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 30 Italy pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 31 Spain pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 32 Spain pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 33 Spain pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 34 Norway pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 35 Norway pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 36 Norway pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 37 Denmark pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 38 Denmark pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 39 Denmark pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 40 Sweden pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 41 Sweden pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 42 Sweden pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 43 Asia Pacific pharmaceutical dissolution testing services market estimates and forecasts, by region, 2021 - 2033 (USD Million)
• Table 44 Japan pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 45 Japan pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 46 Japan pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 47 China pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 48 China pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 49 China pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 50 India pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 51 India pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 52 India pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 53 Australia pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 54 Australia pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 55 Australia pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 56 South Korea pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 57 South Korea pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 58 South Korea pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 59 Thailand pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 60 Thailand pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 61 Thailand pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 62 Latin America pharmaceutical dissolution testing services market estimates and forecasts, by region, 2021 - 2033 (USD Million)
• Table 63 Latin America pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 64 Latin America pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 65 Latin America pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 66 Brazil pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 67 Brazil pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 68 Brazil pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 69 Argentina pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 70 Argentina pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 71 Argentina pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 72 MEA pharmaceutical dissolution testing services market estimates and forecasts, by region, 2021 - 2033 (USD Million)
• Table 73 MEA pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 74 MEA pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 75 MEA pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 76 South Africa pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 77 South Africa pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 78 South Africa pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 79 Saudi Arabia pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 80 Saudi Arabia pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 81 Saudi Arabia pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 82 Kuwait pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 83 Kuwait pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 84 Kuwait pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)
• Table 85 UAE pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
• Table 86 UAE pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
• Table 87 UAE pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Pharmaceutical dissolution testing services market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Commodity flow analysis
• Fig. 8 Value-Chain-Based Sizing & Forecasting
• Fig. 9 QFD model sizing & forecasting
• Fig. 10 Bottom-up approach
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Segment snapshot
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Parent market outlook, 2024 (USD Million)
• Fig. 17 Ancillary market outlook, 2024 (USD Million)
• Fig. 18 Pharmaceutical dissolution testing services market dynamics
• Fig. 19 Total R&D drug pipeline size, 2021 - 2024
• Fig. 20 Total drug pipeline by development phase, 2024
• Fig. 21 Porter's five forces analysis
• Fig. 22 PESTEL analysis
• Fig. 23 Pharmaceutical dissolution testing services market method outlook: Segment dashboard
• Fig. 24 Pharmaceutical dissolution testing services market, by method segment: Market share, 2025 & 2033
• Fig. 25 In-vitro market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 In-vivo market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 Pharmaceutical dissolution testing services market dosage form outlook: Segment dashboard
• Fig. 28 Pharmaceutical dissolution testing services market, by dosage form segment: Market share, 2024 & 2033
• Fig. 29 Capsule market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Tablets market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Other market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 32 Pharmaceutical dissolution testing services market dissolution apparatus outlook: Segment dashboard
• Fig. 33 Pharmaceutical dissolution testing services market, by dissolution apparatus segment: Market share, 2024 & 2033
• Fig. 34 Basket market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 Paddle market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Regional market: Key takeaways
• Fig. 37 Regional marketplace: Key takeaways
• Fig. 38 North America pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 39 Key country dynamics
• Fig. 40 U.S. pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 Key country dynamics
• Fig. 42 Canada pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 Mexico pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 45 Europe pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 UK pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Germany pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 France pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Italy pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Spain pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Denmark pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Norway pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Sweden pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 62 Asia Pacific pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Japan pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 China pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 India pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Australia pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 South Korea pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Thailand pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 75 Latin America pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 Brazil pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Argentina pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 80 MEA pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 South Africa pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Saudi Arabia pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Kuwait pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 UAE pharmaceutical dissolution testing services market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 89 Market participant categorization
• Fig. 90 Heat map analysis

Pharmaceutical Dissolution Testing Services Market Growth & Trends:

The global pharmaceutical dissolution testing services market size is estimated to reach USD 966.3 million by 2033, expanding at a CAGR of 8.98% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is expected to increase primarily as a result of the rising drug development process, increasing technological advancements, rising awareness about the need for high-quality products, and the production of numerous medications for various chronic diseases that require dissolution testing. The COVID-19 pandemic has significantly impacted the global industry. Pharmaceutical firms, biotech firms, and other end-user demands were primarily served during the crisis by developing coronavirus prevention drugs.

Since the end of 2019, these organizations have been actively working toward the development of medications that can be used as a treatment for COVID-19 patients who have only minor symptoms. And these drug developments require dissolution testing at each stage to access safety, stability, and efficacy, thus contributing to industry growth. For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.

Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient's system and whether any negative effects brought on by slower absorption rates would occur. Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.

Pharmaceutical Dissolution Testing Services Market Report Highlights:

• The in vitro method segment accounted for the largest revenue share in 2024
• The tablets dosage form segment accounted for the largest share and is anticipated to grow at the fastest CAGR during the forecast period
• Tablets have high physical and chemical stability and the amount of drug delivered to the body can be controlled
• Based on dissolution apparatus, the paddle segment dominated the industry in 2024 as it can cover a range of oral dosage forms
• North America dominated the industry in 2024 owing to rising investments by public firms in research and their state-of-the-art research infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Value chain based analysis (Model 2)
  • 1.7.3. Multivariate Analysis (Model 3)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Pharmaceutical Dissolution Testing Services Market: Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Pharmaceutical Dissolution Testing Services Market Dynamics
  • 3.2.1. Market Driver Impact Analysis
    • 3.2.1.1. Increasing R&D activities
    • 3.2.1.2. Rising burden of chronic and infectious diseases supporting demand for dissolution testing of drugs
    • 3.2.1.3. Rising use of generic drugs
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Increased effort for method validation
• 3.3. Technological Landscape
• 3.4. Pricing Model Analysis
• 3.5. Pharmaceutical Dissolution Testing Services Market: Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL Analysis

Chapter 4. Pharmaceutical Dissolution Testing Services Market: Method Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Pharmaceutical Dissolution Testing Services Market Movement Analysis
• 4.3. Global Pharmaceutical Dissolution Testing Services Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
• 4.4. In-Vitro
  • 4.4.1. In-Vitro Market Estimates and Forecasts, 2021 - 2033 (USD million)
• 4.5. In-vivo
  • 4.5.1. In-Vivo Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pharmaceutical Dissolution Testing Services Market: Dosage Form Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Pharmaceutical Dissolution Testing Services Market Movement Analysis
• 5.3. Global Pharmaceutical Dissolution Testing Services Market Size & Trend Analysis, by Dosage form, 2021 to 2033 (USD Million)
• 5.4. Capsule
  • 5.4.1. Capsule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Tablets
  • 5.5.1. Tablets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pharmaceutical Dissolution Testing Services Market: Dissolution Apparatus Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Pharmaceutical Dissolution Testing Services Market Movement Analysis
• 6.3. Global Pharmaceutical Dissolution Testing Services Market Size & Trend Analysis, by dissolution apparatus, 2021 to 2033 (USD Million)
• 6.4. Basket
  • 6.4.1. Basket Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Paddle
  • 6.5.1. Paddle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pharmaceutical Dissolution Testing Services Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

• 7.1. Regional Market Dashboard
• 7.2. Global Regional Market Snapshot
• 7.3. Market Size, & Forecasts, Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Pharmaceutical Dissolution Testing Services Market Share Analysis, 2024
• 8.3. Company Profiles
  • 8.3.1. Intertek Group Plc.
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Avivia BV
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Almac Group
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Agilent Technologies, Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Catalent, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Thermo Fisher Scientific Inc.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Cambrex
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Charles River Laboratories
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Boston Analytical
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Pace Analytical Life Sciences
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. SOTAX
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. AMRI
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. SGS SA
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives